Lisdexamfetamine, marketed as Vyvanse, is a prescription medication approved for attention deficit hyperactivity disorder in youngsters and adults . In Canada, its distribution is managed by Health Canada. https://apo-lisdexamfetamine-pri514284.reflectblog.com/561485/vyvanse-in-canada-a-comprehensive-guide